Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.53
-0.16 (-2.81%)
At close: Mar 5, 2026, 4:00 PM EST
5.55
+0.02 (0.36%)
After-hours: Mar 5, 2026, 7:55 PM EST

Compass Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
35
Market Cap
983.58M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025---
Dec 31, 2024850.00K--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 2.72B
Xeris Biopharma Holdings 291.85M
Valneva SE 211.09M
Maravai LifeSciences Holdings 185.74M
UroGen Pharma 109.79M
Inhibrx Biosciences 1.40M
Revenue Rankings